Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AbbVie Partnership On CD71 Gives CytomX Big Upfront, Co-Promotion Potential

Related Content

Bristol-Myers commits up to $1.2bn in CytomX deal

May 28 2014

BioNotebook: Seattle Genetics/AbbVie, Auspex, Flexion, Ironwood

Jan 09 2014

AbbVie Partners With Argenx In Cancer Deal Spree

Apr 25 2016

Abbott accesses Seattle Genetics' ADC technology for a single oncology target

Mar 23 2011

Is the Biotech IPO Window Closing?

Oct 22 2015

Pfizer enters deal for targeted cancer drugs

Jun 07 2013

Related Companies

AbbVie Inc.

CytomX Therapeutics, Inc.

Pfizer Inc.

Bristol Myers Squibb Company

University of Chicago

Abbott

Seagen Inc.

Additional Topics

Companies Deals Cancer

More from Anticancer

More from Therapeutic Category

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window